
TY  - JOUR
AU  - Helm, C. William
TI  - The Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
JO  - The Oncologist
JA  - The Oncol
VL  - 14
IS  - 7
SN  - 1083-7159
UR  - https://doi.org/10.1634/theoncologist.2008-0275
DO  - doi:10.1634/theoncologist.2008-0275
SP  - 683
EP  - 694
KW  - Hyperthermic intraperitoneal chemotherapy (HIPEC)
KW  - Ovarian neoplasms
KW  - Intraperitoneal chemotherapy
KW  - Hyperthermia
KW  - Cytoreductive surgery
PY  - 2009
AB  - Overall outcomes for women with epithelial ovarian cancer (EOC) remain relatively poor, and superior methods of treatment are needed. EOC is a peritoneal surface malignancy that is relatively sensitive to chemotherapy agents, making it a good target for i.p. chemotherapy. Because there is strong laboratory data demonstrating the ability of hyperthermia to increase the efficacy of chemotherapeutic agents, the addition of hyperthermia to i.p. chemotherapy, hyperthermic intraperitoneal chemotherapy (HIPEC), makes theoretical sense. This article reviews the current literature and discusses the possible role for HIPEC in EOC at significant natural history time points: front line, at the time of interval debulking, in consolidation, and for recurrent disease. The conclusion is that much further research is needed but that HIPEC could sensibly be researched at all the natural history time points in EOC.
ER  - 

TY  - JOUR
TI  - Second Scandinavian Congress of Sports Medicine, Copenhagen, Denmark, November 24–27, 1994
JO  - Scandinavian Journal of Medicine & Science in Sports
VL  - 4
IS  - 4
SN  - 0905-7188
UR  - https://doi.org/10.1111/j.1600-0838.1994.tb00439.x
DO  - doi:10.1111/j.1600-0838.1994.tb00439.x
SP  - 261
EP  - 287
PY  - 1994
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 34
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1002/phar.1497
DO  - doi:10.1002/phar.1497
SP  - e180
EP  - e332
PY  - 2014
ER  - 

TY  - JOUR
TI  - Front Index and Abstracts
JO  - International Journal of Stroke
JA  - Int J Stroke
VL  - 8
IS  - S3
SN  - 1747-4930
UR  - https://doi.org/10.1111/ijs.12213
DO  - doi:10.1111/ijs.12213
SP  - vii
EP  - 75
PY  - 2013
ER  - 

TY  - JOUR
TI  - ACCP Annual Meeting-Abstracts and index of authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 11
IS  - 3
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1991.tb02638.x
DO  - doi:10.1002/j.1875-9114.1991.tb02638.x
SP  - 264
EP  - 290
PY  - 1991
ER  - 

TY  - JOUR
AU  - Neumann, Tim
AU  - Spies, Claudia
TI  - Use of biomarkers for alcohol use disorders in clinical practice
JO  - Addiction
VL  - 98
IS  - s2
SN  - 0965-2140
UR  - https://doi.org/10.1046/j.1359-6357.2003.00587.x
DO  - doi:10.1046/j.1359-6357.2003.00587.x
SP  - 81
EP  - 91
KW  - Alcohol
KW  - biomarkers
KW  - clinical
KW  - comorbidity
KW  - screening
PY  - 2003
AB  - ABSTRACT Background? Biomedical markers may provide additive objective information in screening and confirmation of acute or recent consumption, intoxication, relapse, heavy drinking, hazardous/harmful use/abuse and dependence and alcohol use related organ dysfunction (alcohol use-related disorders: AUDs). Aims? To review the use of biomarkers in clinical practice to detect AUDs. Findings? About one-fifth of the patients seen in clinical practice have AUDs, which offer a variety of treatment options if diagnosed. The diagnosis of AUDs relies on clinical and alcohol-related history, physical examination, questionnaires and laboratory values. No clinical available laboratory test [e.g. for acute abuse: alcohol in blood or breath; for chronic alcohol abuse: ?-glutamyl transferase (GGT), mean corpuscular volume (MCV), carbohydrate-deficient transferrin (CDT)] is reliable enough on its own to support a diagnosis of alcohol dependence, harmful use or abuse. Sensitivities, specificities and the predictive values may vary considerably according to patient and control group characteristics (e.g. gender, age or related comorbidity). In patient groups with limited cooperation markers may be helpful when considering treatment options. Conclusions? More research is needed to determine the value of markers (single or combined, with questionnaires) in the context of clinical decision-making algorithms in defined settings and with defined dichotomous outcome variables.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Haemophilia
VL  - 16
IS  - s4
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2010.02283.x
DO  - doi:10.1111/j.1365-2516.2010.02283.x
SP  - 1
EP  - 158
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster presentation: Thursday 30 August 2007
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 101
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2007.00104.x
DO  - doi:10.1111/j.1742-7843.2007.00104.x
SP  - 103
EP  - 157
PY  - 2007
ER  - 

TY  - JOUR
TI  - Saturday 24th October 2009, 0700–0830
JO  - Journal of Medical Imaging and Radiation Oncology
VL  - 53
IS  - s1
SN  - 1754-9477
UR  - https://doi.org/10.1111/j.1440-1673.2009.01209.x
DO  - doi:10.1111/j.1440-1673.2009.01209.x
SP  - A73
EP  - A162
PY  - 2009
ER  - 

TY  - JOUR
TI  - SARS Abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 103
IS  - S3
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.10158
DO  - doi:10.1002/bjs.10158
SP  - 6
EP  - 49
PY  - 2016
ER  - 

TY  - JOUR
TI  - Oral Presentation
JO  - International Journal of Stroke
JA  - Int J Stroke
VL  - 10
IS  - S2
SN  - 1747-4930
UR  - https://doi.org/10.1111/ijs.12478
DO  - doi:10.1111/ijs.12478
SP  - 1
EP  - 76
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Australasian Radiology
VL  - 51
IS  - s2
SN  - 0004-8461
UR  - https://doi.org/10.1111/j.1440-1673.2007.01878.x
DO  - doi:10.1111/j.1440-1673.2007.01878.x
SP  - A1
EP  - A23
PY  - 2007
ER  - 

TY  - JOUR
TI  - Thirteenth Annual Meeting August 9–12, 1992. Harbour Castle Westin Toronto, Ontario, Canada
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 12
IS  - 3
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1992.tb04517.x
DO  - doi:10.1002/j.1875-9114.1992.tb04517.x
SP  - 244
EP  - 268
PY  - 1992
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 289–2348)
JO  - Hepatology
JA  - Hepatology
VL  - 70
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30941
DO  - doi:10.1002/hep.30941
SP  - 188
EP  - 1382
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
VL  - 5
IS  - s11
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6135.2005.abstracts.x
DO  - doi:10.1111/j.1600-6135.2005.abstracts.x
SP  - 155
EP  - 576
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 10
IS  - s3
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2004.0902d.x
DO  - doi:10.1111/j.1469-0691.2004.0902d.x
SP  - 274
EP  - 365
PY  - 2004
ER  - 

TY  - JOUR
AU  - Hall, H. Roe Bartle
TI  - ACCP 1999 Annual Meeting Abstracts
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 19
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.19.15.1191.30577
DO  - doi:10.1592/phco.19.15.1191.30577
SP  - 1191
EP  - 1240
PY  - 1999
ER  - 

TY  - JOUR
TI  - The society for cardiovascular angiography and interventions' 36th annual scientific sessions
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 81
IS  - S1
SN  - 1522-1946
UR  - https://doi.org/10.1002/ccd.24919
DO  - doi:10.1002/ccd.24919
SP  - S1
EP  - S173
PY  - 2013
ER  - 

TY  - JOUR
TI  - Clinical Psychology
JO  - International Journal of Psychology
JA  - Int J Psychol
VL  - 51
IS  - S1
SN  - 0020-7594
UR  - https://doi.org/10.1002/ijop.12298
DO  - doi:10.1002/ijop.12298
SP  - 82
EP  - 158
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** 2001 Annal Meeting Walt Disney Dolphin Orlando, Florida, March 6–10, 2001*
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 69
IS  - 2
SN  - 0009-9236
UR  - https://doi.org/10.1016/S0009-9236(01)90087-6a
DO  - doi:10.1016/S0009-9236(01)90087-6a
SP  - P1
EP  - P95
PY  - 2001
AB  - Clinical Pharmacology  doi: 10.1016/S0009-9236(01)90087-6a
ER  - 
